Atlas Trials

FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)

Clinical trial NCT03422510 · COMPLETED

Trial details

NCT number
NCT03422510
Sponsor
Complexa, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Focal Segmental Glomerulosclerosis
Start date
2018-04-15
Primary completion
2020-07-31
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.